0
0

Department of Justice Awarded a Contract to ACTELION PHARMACEUTICALS US, INC. for $12,540.07

Signed on

8/5/2025, 12:00 AM

ACTELION PHARMACEUTICALS US, INC. Government Contract #15B41825F00000328

ACTELION PHARMACEUTICALS US, INC. was awarded a contract with the United States Government for $12,540.07. The contract was awarded by the agency office USP TERRE HAUTE, which is a division with the Federal Prison System / Bureau of Prisons within the Department of Justice.

Summary of Award

The recipient of the federal contract is Actelion Pharmaceuticals US, Inc., a U.S.-owned business that manufactures pharmaceutical goods. The contract, funded by the Department of Justice's Federal Prison System, is for supplying drugs and biologicals, specifically FY25 B1 Curascript Opsumit Meds, with a total value of $12,540.07. Notable details include the recipient location in Titusville, New Jersey, and the contract is subject to full and open competition with one offer received.

Contract Details

Contract ID15B41825F00000328
Contract TypeC
Total Obligation$12,540.07
Exercised Options$12,540.07
Base Amount + Options$12,540.07
Date Signed2025-08-05
Contract DescriptionFY25 B1 CURASCRIPT OPSUMIT MEDS AUG25
Start Date2025-08-01
End Date2025-08-31

Agency Details

Awarding AgencyDepartment of Justice
Awarding Sub AgencyFederal Prison System / Bureau of Prisons
Awarding OfficeUSP TERRE HAUTE
Funding AgencyDepartment of Justice
Funding Sub AgencyFederal Prison System / Bureau of Prisons
Funding OfficeUSP TERRE HAUTE

Recipient Details

RecipientACTELION PHARMACEUTICALS US, INC.
Recipient Location1125 TRENTON HARBOURTON RD # 1 TITUSVILLE NEW JERSEY, UNITED STATES
Business CategoriesCategory Business, Corporate Entity Not Tax Exempt, Manufacturer of Goods, Not Designated a Small Business, Special Designations, U.S.-Owned Business

Comments

Award Transactions